Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ

INTRODUCTION: Ductal carcinoma in situ (DCIS) is a noninvasive premalignant lesion and is considered a precursor to invasive carcinoma. DCIS accounts for nearly 20% of newly diagnosed breast cancer, but the lack of experimentally amenable in vivo DCIS models hinders the development of treatment stra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Namba, Ruria, Young, Lawrence JT, Maglione, Jeannie E, McGoldrick, Erik T, Liu, Stephenie, Wurz, Gregory T, DeGregorio, Michael W, Borowsky, Alexander D, MacLeod, Carol L, Cardiff, Robert D, Gregg, Jeffrey P
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2005
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1410776/
https://ncbi.nlm.nih.gov/pubmed/16280035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr1317
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars